Advanced Cell Technology (ACTC.OB) Provides Update on Embryonic Stem Cell Clinical Trials
Advanced Cell Technology, Inc., an emerging biotechnology company that specializes in the development of cellular therapies for the treatment of rare and common diseases that impact millions of people worldwide, recently announced an update regarding its clinical trials utilizing embryonic stem cells to treat eye disease. Advanced Cell Technology has received notification from the U.S. Food and Drug Administration (FDA) that the agency is currently drafting a response regarding its Investigational New Drug application it filed in November 2009. Advanced Cell Technology expects a response from the FDA within the next few weeks. William M. Caldwell IV, Advanced Cell Technology’s…